Highlander Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-14,000
| Closed | -$125K | – | 766 |
|
|
2017
Q2 | $125K | Sell |
14,000
-2,500
| -15% | -$22.3K | 0.1% | 219 |
|
|
2017
Q1 | $86K | Sell |
16,500
-1,000
| -6% | -$5.21K | 0.07% | 267 |
|
|
2016
Q4 | $53K | Sell |
17,500
-20,500
| -54% | -$62.1K | 0.05% | 322 |
|
|
2016
Q3 | $176K | Sell |
38,000
-5,000
| -12% | -$23.2K | 0.16% | 166 |
|
|
2016
Q2 | $249K | Sell |
43,000
-1,000
| -2% | -$5.79K | 0.23% | 125 |
|
|
2016
Q1 | $266K | Sell |
44,000
-9,000
| -17% | -$54.4K | 0.25% | 114 |
|
|
2015
Q4 | $484K | Sell |
53,000
-5,600
| -10% | -$51.1K | 0.45% | 56 |
|
|
2015
Q3 | $330K | Buy |
58,600
+15,100
| +35% | +$85K | 0.31% | 88 |
|
|
2015
Q2 | $482K | Buy |
43,500
+36,000
| +480% | +$399K | 0.43% | 61 |
|
|
2015
Q1 | $118K | Buy |
+7,500
| New | +$118K | 0.1% | 227 |
|